International Stem Cell CORP (ISCO) › Shareholders' EquityInternational Stem Cell CORP (ISCO) — Shareholders' EquityAnnual figures by period end, from SEC filings.2006-12-31: $4.70M2007-12-31: $212.0K2008-12-31: $433.0K2009-12-31: -$2.27M2010-12-31: $5.39M2011-12-31: $3.62M2012-12-31: -$1.76M2013-12-31: -$4.22M2014-12-31: $321.0K2015-12-31: $1.59M2016-12-31: $3.44M2017-12-31: $2.06M2018-12-31: $2.54M2019-12-31: -$2.89M2020-12-31: -$4.33M2021-12-31: -$4.59M2022-12-31: -$4.52M2023-12-31: -$4.19M2024-12-31: -$3.93M2025-12-31: -$4.06M-$4.06M2006-12-31Shareholders' Equity (USD)2025-12-31Period endedShareholders' EquityChange YoYSource filing2025-12-31-$4.06M—2026-03-30Balance as of period end2024-12-31-$3.93M—2026-03-30Balance as of period end2023-12-31-$4.19M—2026-03-30Balance as of period end2022-12-31-$4.52M—2025-03-28Balance as of period end2021-12-31-$4.59M—2024-03-28Balance as of period end2020-12-31-$4.33M—2023-03-30Balance as of period end2019-12-31-$2.89M-213.8%2022-03-29Balance as of period end2018-12-31$2.54M+22.9%2021-03-30Balance as of period end2017-12-31$2.06M-40.1%2020-06-01Balance as of period end2016-12-31$3.44M+116.1%2019-04-15Balance as of period end2015-12-31$1.59M+396.6%2018-04-09Balance as of period end2014-12-31$321.0K—2017-03-31Balance as of period end2013-12-31-$4.22M—2016-03-30Balance as of period end2012-12-31-$1.76M-148.5%2015-03-30Balance as of period end2011-12-31$3.62M-32.8%2014-03-17Balance as of period end2010-12-31$5.39M—2013-03-26Balance as of period end2009-12-31-$2.27M-624.2%2013-03-26Balance as of period end2008-12-31$433.0K+104.2%2013-03-26Balance as of period end2007-12-31$212.0K-95.5%2013-03-26Balance as of period end2006-12-31$4.70M—2013-03-26Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)